No new concerns for GLP-1 therapies identified on the basis of available evidence (European Medicines Agency)
Diabetes News Service
No new concerns for GLP-1 therapies identified on the basis of available evidence (European Medicines Agency)
For iPhone and iPad | For Android devices
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
Website by Wired up Wales